Generic Drug News and Research

RSS

Generic Drugs are official nonbrand names by which medicines are known. Generic names usually refer to the chemical name of the drug.

Major variations in Medicare drug costs

Soon, Congress may vote on whether to require the Medicare system to negotiate lower prices for medicines taken by millions of seniors enrolled in Medicare Part D prescription drug plans.

10 Jan 2007

India's decision to abide to pharma patents could limit access to medicines

India has become the "premier drug provider for the developing world" by producing generic versions of some of the world's most effective medicines, including antiretroviral drugs, but the country's decision to adhere to international patent regulations could limit access to generic drugs in the developing world, the Christian Science Monitor reports.

9 Jan 2007

Use of statins and beta-blockers as prescribed following heart attack associated with living longer

New research suggests that the pharmacological effects of taking medications such as statins and beta-blockers as prescribed following a heart attack is associated with living longer, according to a study in the January 10 issue of JAMA: The Journal of the American Medical Association.

9 Jan 2007

MedImmune statement on MedImmune vs. Genentech Supreme Court decision

MedImmune issued the following statement regarding today's U.S. Supreme Court decision in MedImmune, Inc. vs. Genentech, Inc. et al.

9 Jan 2007

Ranbaxy granted approval to manufacture Atenolol

Ranbaxy Laboratories has announced that the Company has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market Atenolol Tablets USP, 25 mg, 50 mg, and 100 mg.

2 Jan 2007

FDA announces tentative approval of generic Zoloft

Lupin Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Sertraline Hydrochloride Tablets, 25mg, 50mg and 100mg.

2 Jan 2007

Older schizophrenia drugs cheaper and work just as well

According to a new study an older antipsychotic drug has been found to be both cheaper and as effective for some patients with schizophrenia as the newer drugs on the market.

4 Dec 2006

Thai Health Ministry to issue compulsory license for Merck's HIV/AIDS drug Efavirenz

Thailand's Ministry Of Public Health on Wednesday announced plans to issue a compulsory license to produce a lower-cost version of Merck's antiretroviral drug Efavirenz, Reuters reports.

2 Dec 2006

Schizophrenia treatment with older, generic antipsychotics cheaper, as effective as treatment with newer drugs

Treating schizophrenia patients with older, less expensive antipsychotic drugs reduces overall treatment costs by up to 30% and produces no increase in side effects or decrease in effectiveness compared with newer, brand-name medications.

2 Dec 2006

Target to expand discounted generic drug program to all pharmacies

The Minneapolis-based company said all of its 1,287 pharmacies now will offer a 30-day supply of certain generic drugs for $4. The company previously offered the program only in states where Wal-Mart was offering generic drugs at the same price (Reuters/New York Times, 11/21).

23 Nov 2006

Wal-Mart generic drug discount program indicates markets can provide medications at affordable prices

The generic prescription drug discount program introduced earlier this year by Wal-Mart Stores indicates that "markets are, in fact, capable of providing medicines at affordable prices," Peter Pitts, director of the Center for Medicine in the Public Interest and a former associate commissioner at FDA, writes in a Baltimore Sun opinion piece.

23 Nov 2006

Templated self-assembly of quantum dots from aqueous solution using protein scaffolds

Quantum dots are rapidly becoming biomedical researchers' tool of choice for adding a fluorescent label to a wide variety of biomolecules.

20 Nov 2006

Doha Declaration on life-saving drugs for poor countries not happening

Despite the fact that the World Trade Organisation (WTO) granted a special exemption five years ago, in order that poor countries could access life-saving drug, poor people in developing countries are still dying needlessly because global pharmaceutical giants continue to monopolise drugs for diseases such as cancer and AIDS.

15 Nov 2006

MSF, Oxfam call on wealthy nations to adhere to WTO guidelines to ensure drug access in developing countries

Medecins Sans Frontieres and Oxfam on Tuesday called on developed nations to adhere to the World Trade Organization's Agreement on Trade-Related Aspects of Intellectual Property Rights to ensure universal access to antiretroviral drugs in developing countries, the AP/International Herald Tribune reports (Higgins, AP/International Herald Tribune, 11/14).

14 Nov 2006

Generic Drug News and Research

Further Reading

Major variations in Medicare drug costs

India's decision to abide to pharma patents could limit access to medicines

Use of statins and beta-blockers as prescribed following heart attack associated with living longer

MedImmune statement on MedImmune vs. Genentech Supreme Court decision

Ranbaxy granted approval to manufacture Atenolol

FDA announces tentative approval of generic Zoloft

Older schizophrenia drugs cheaper and work just as well

Thai Health Ministry to issue compulsory license for Merck's HIV/AIDS drug Efavirenz

Schizophrenia treatment with older, generic antipsychotics cheaper, as effective as treatment with newer drugs

Target to expand discounted generic drug program to all pharmacies

Wal-Mart generic drug discount program indicates markets can provide medications at affordable prices

Templated self-assembly of quantum dots from aqueous solution using protein scaffolds

Doha Declaration on life-saving drugs for poor countries not happening

MSF, Oxfam call on wealthy nations to adhere to WTO guidelines to ensure drug access in developing countries

Drug industry concerned about California Law allowing State to seek drug discounts

Pfizer provides opinion on European Lipitor patent

Wal-Mart expands generic prescription drug discount program

Zimbabwean Government to Delay enrollment of additional HIV-positive people in drug treatment program

Washington, D.C., to offer caremark Rx discount cards to all residents

FDA advisory panel recommends adding warning label to Tamoxifen

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News